These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30458933)

  • 1. On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines.
    Scavone C; Carnovale C; Ruggiero R; Radice S; Scatigna M; Racagni G; Mugelli A; Rossi F; Clementi E; Capuano A
    Clin Ther; 2018 Nov; 40(11):1931-1940. PubMed ID: 30458933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veneto Region, Italy. Health system review.
    Toniolo F; Mantoan D; Maresso A
    Health Syst Transit; 2012; 14(1):i-xix, 1-138. PubMed ID: 22575766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The healthcare system and the provision of oral healthcare in European Union member states. Part 8: Italy.
    Bindi M; Paganelli C; Eaton KA; Widström E
    Br Dent J; 2017 May; 222(10):809-817. PubMed ID: 28546591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review.
    Babar ZU; Gammie T; Seyfoddin A; Hasan SS; Curley LE
    Res Social Adm Pharm; 2019 Mar; 15(3):231-243. PubMed ID: 29678413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fiscal decentralization in the Italian NHS: what happens to interregional redistribution?
    Ferrario C; Zanardi A
    Health Policy; 2011 Apr; 100(1):71-80. PubMed ID: 20864204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Government review aims to speed up NHS access to new medicines.
    Hawkes N
    BMJ; 2014 Nov; 349():g7090. PubMed ID: 25422172
    [No Abstract]   [Full Text] [Related]  

  • 7. Provision of pharmaceuticals in Australian hospitals: equity of access?
    Gallego G; Taylor SJ; Brien JA
    Pharm World Sci; 2007 Apr; 29(2):47-50. PubMed ID: 17149650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis and reflections on the 2019 initiative that reforms Mexico's Ley General de Salud].
    Reyes-Morales H; Dreser-Mansilla A; Arredondo-López A; Bautista-Arredondo S; Ávila-Burgos L
    Salud Publica Mex; 2019; 61(5):685-691. PubMed ID: 31661746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powerful Ideas for Global Access to Medicines.
    Moon S
    N Engl J Med; 2017 Feb; 376(6):505-507. PubMed ID: 28099819
    [No Abstract]   [Full Text] [Related]  

  • 10. The "Essential Levels of Care" in Italy: when being explicit serves the devolution of powers.
    Torbica A; Fattore G
    Eur J Health Econ; 2005 Dec; Suppl(Suppl 1):46-52. PubMed ID: 16258750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Italian health-care system.
    France G; Taroni F; Donatini A
    Health Econ; 2005 Sep; 14(Suppl 1):S187-202. PubMed ID: 16161196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicines in Mexico, 1990-2004: systematic review of research on access and use.
    Wirtz VJ; Reich MR; Leyva Flores R; Dreser A
    Salud Publica Mex; 2008; 50 Suppl 4():S470-9. PubMed ID: 19082258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation and adoption of health technologies under Brazil's Unified Health System: barriers to access to medicines for diseases of poverty?
    Santana RS; Lupatini EO; Leite SN
    Cien Saude Colet; 2017 May; 22(5):1417-1428. PubMed ID: 28538914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protection of the access to medicines right among disabled people.].
    Puzin SN; Grechko AV; Prianikov IV; Malichenko VS; Puzin SS
    Adv Gerontol; 2018; 31(4):581-587. PubMed ID: 30607924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Services and comprehensiveness 30 years after the advent of Brazil's Unified Health System.
    Bermudez JAZ; Esher A; Osorio-de-Castro CGS; Vasconcelos DMM; Chaves GC; Oliveira MA; Silva RMD; Luiza VL
    Cien Saude Colet; 2018 Jun; 23(6):1937-1949. PubMed ID: 29972501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing 15 proposals for promoting innovation and access to medicines globally.
    Hoffman SJ; So K;
    Ann Glob Health; 2014; 80(6):432-43. PubMed ID: 25960092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italy's contribution to global health: the need for a paradigm shift.
    Missoni E; Tediosi F; Pacileo G; Gautier L
    Global Health; 2014 Apr; 10():25. PubMed ID: 24708890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of China's national essential medicines policy.
    Guan X; Liang H; Xue Y; Shi L
    J Public Health Policy; 2011 Aug; 32(3):305-19. PubMed ID: 21614030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to medicines by ambulatory health service users in Mexico: an analysis of the national health surveys 1994 to 2006.
    Wirtz VJ; Russo G; Kageyama-Escobar Mde L
    Salud Publica Mex; 2010; 52(1):30-8. PubMed ID: 20464251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of Guaranteeing Access to Medicines in Mexico: Lessons from Recent Changes in Pharmaceuticals Procurement.
    Gómez-Dantés O; Dreser A; Wirtz VJ; Reich MR
    Health Syst Reform; 2022 Jan; 8(1):2084221. PubMed ID: 35723656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.